These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Prognosis
11 results:

  • 1. Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study.
    Guo X; Jin W; Wen Y; Wang Z; Ren X; Liu Z; Fu R; Cai Z; Li L
    J Transl Med; 2024 Jul; 22(1):673. PubMed ID: 39033303
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A deconvolution method and its application in analyzing the cellular fractions in acute myeloid leukemia samples.
    Li H; Sharma A; Ming W; Sun X; Liu H
    BMC Genomics; 2020 Sep; 21(1):652. PubMed ID: 32967610
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia.
    Han H; Byun JM; Shin DY; Yoon SS; Koh Y; Hong J; Kim I; Lee C; Yoo H; Yun H; Kim MJ; Cho SI; Seong MW; Park SS
    Korean J Intern Med; 2021 Mar; 36(2):401-412. PubMed ID: 32811132
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets.
    Hoell JI; Ginzel S; Kuhlen M; Kloetgen A; Gombert M; Fischer U; Hein D; Demir S; Stanulla M; Schrappe M; Zur Stadt U; Bader P; Babor F; Schuster F; Strahm B; Alten J; Moericke A; Escherich G; von Stackelberg A; Thiele R; McHardy AC; Peters C; Bornhauser B; Bourquin JP; Krause S; Enczmann J; Meyer LH; Eckert C; Borkhardt A; Meisel R
    Blood Adv; 2019 Oct; 3(20):3143-3156. PubMed ID: 31648313
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clonal evolution mechanisms in nt5c2 mutant-relapsed acute lymphoblastic leukaemia.
    Tzoneva G; Dieck CL; Oshima K; Ambesi-Impiombato A; Sánchez-Martín M; Madubata CJ; Khiabanian H; Yu J; Waanders E; Iacobucci I; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Kirschner-Schwabe R; Mullighan CG; Rabadan R; Ferrando AA
    Nature; 2018 Jan; 553(7689):511-514. PubMed ID: 29342136
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
    Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
    J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [PRPS1 Expression in Children with Acute leukemia and Its Clinical Significance].
    Ma YM; An XZ; Guan XM; Kong QL; Li PF; Xian Y; Xiao JW; Meng Y; Liang SY; Yu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):311-317. PubMed ID: 28446267
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [nt5c2 expression in children with acute leukemia and its clinical significance].
    Wang Y; An X; Liu J; Zhang N; Liu Z; Liang S; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):748-53. PubMed ID: 26462774
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Relapse-specific mutations in nt5c2 in childhood acute lymphoblastic leukemia.
    Meyer JA; Wang J; Hogan LE; Yang JJ; Dandekar S; Patel JP; Tang Z; Zumbo P; Li S; Zavadil J; Levine RL; Cardozo T; Hunger SP; Raetz EA; Evans WE; Morrison DJ; Mason CE; Carroll WL
    Nat Genet; 2013 Mar; 45(3):290-4. PubMed ID: 23377183
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cell of origin determines clinically relevant subtypes of MLL-rearranged AML.
    Krivtsov AV; Figueroa ME; Sinha AU; Stubbs MC; Feng Z; Valk PJ; Delwel R; Döhner K; Bullinger L; Kung AL; Melnick AM; Armstrong SA
    Leukemia; 2013 Apr; 27(4):852-60. PubMed ID: 23235717
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.
    Perrotti D; Harb JG
    Leuk Lymphoma; 2011 Feb; 52 Suppl 1(Suppl 1):30-44. PubMed ID: 21299458
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.